Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma

Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI

(2013) Mi Jeong Lee et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma

(2013) Maria M Caffarel et al.   JOURNAL OF PATHOLOGY

Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling

(2013) Malin Lando et al.   JOURNAL OF PATHOLOGY

Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition

(2013) L Guo et al.   ONCOGENE

Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer

(2013) N R West et al.   ONCOGENE

Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer

(2013) Karina L. Mine et al.   Nature Communications

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer

(2012) Nathan R West et al.   ENDOCRINE-RELATED CANCER

Genital human papillomavirus infections: current and prospective therapies

(2012) M. A. Stanley   JOURNAL OF GENERAL VIROLOGY

Patient-derived tumour xenografts as models for oncology drug development

(2012) John J. Tentler et al.   Nature Reviews Clinical Oncology

TG2, a novel extracellular protein with multiple functions

(2011) Zhuo Wang et al.   AMINO ACIDS

Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?

(2011) Santosh Kumar et al.   AMINO ACIDS

Treatment of cervical cancer precursors: influence of age, completeness of excision and cone depth on therapeutic failure, and on adverse obstetric outcomes

(2011) M Arbyn et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

c-MYC Functions as a Molecular Switch to Alter the Response of Human Mammary Epithelial Cells to Oncostatin M

(2011) C. E. Kan et al.   CANCER RESEARCH

Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness

(2011) David M Winder et al.   JOURNAL OF PATHOLOGY

Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles

(2011) Balaji Muralidhar et al.   JOURNAL OF PATHOLOGY

Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma

(2011) Tasneem Kausar et al.   CELLULAR ONCOLOGY

Rheumatoid arthritis therapy: Advances from bench to bedside

(2010) Soo-In Choi et al.   AUTOIMMUNITY

Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis

(2010) Gopeshwar Narayan et al.   Future Oncology

Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas

(2008) DR Chen et al.   JOURNAL OF PATHOLOGY

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha

(2008) Luigi Scotto et al.   Molecular Cancer